Suero, Mark Kloe C.
HRN: 22-28-62 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
CEFUROXIME 750MG (VIAL)
12/03/2022
12/10/2022
IVT
200 Mg
Q8
Pcap C
Waiting Final Action
12/06/2022
CEFTAZIDIME 1GM (VIAL)
12/06/2022
12/13/2022
IV
160mg
Q8hrs
PCAP C
Waiting Final Action
04/02/2023
CEFUROXIME 1.5GM (VIAL)
04/02/2023
04/05/2023
IV
240mg
Q8
URTI
Waiting Final Action